Wolverine Trading, LLC Vir Biotechnology, Inc. Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $86,982 - $144,324	11,400 New	11,400 $101,000
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $183,632 - $259,624	9,200 New	9,200 $233,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $286,200 - $400,500	15,000 New	15,000 $390,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $629,343 - $1.19 Million	-29,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $449,065 - $783,435	14,500 Added 95.39%	29,700 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $247,790 - $387,234	7,100 Added 87.65%	15,200 $656,000
Q2 2021 Aug 06, 2021	SELL	$38.75 - $51.0 $418,500 - $550,800	-10,800 Reduced 57.14%	8,100 $377,000
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $497,826 - $1.57 Million	18,900 New	18,900 $903,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.